Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Medico Intercontinental Ltd

Your Vote -

Buy

50.00%

Hold

33.33%

Sell

16.67%

50.00%

6 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Medico Intercontinental Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Medico Intercontinen Q4 net profit down 20.75% at Rs 0.42 cr

    22 May 2026, 1:50PM The company reported standalone net profit of Rs 0.42 crore for the quarter ended March 31, 2026 as compared to Rs 0.53 crore in the same period last
  • Medico Intercontinen - Announcement under Regulation 30 (LODR)-Meeting Updates

    22 May 2026, 1:23PM Intimation of Re-appointment of an Internal Auditors.
  • Medico Intercontinen - Results - Financial Year Ended March 31, 2026.

    22 May 2026, 1:16PM Results for the quarter and financial year ended March 31, 2026
  • Medico Intercontinen - Board Meeting Outcome for Outcome Of Board Meeting Dated May 22, 2026

    22 May 2026, 1:03PM Outcome of Board meeting dated May 22, 2026.
  • Medico Intercontinen - Board Meeting Intimation for Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (List

    14 May 2026, 12:43PM Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consi
  • Medico Intercontinen has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    8 Apr 2026, 12:10PM As of March 2026, 57.15% is owned by Indian Promoters and 42.85% by Public. <p align=justify> Top two Promoters holding highest number of shares of Me
  • Medico Intercontinen - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    8 Apr 2026, 10:31AM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Medico Intercontinen - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    4 Apr 2026, 12:18PM Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

Key fundamentals

Evaluate the intrinsic value of Medico Intercontinental Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 56.9923 51.8773 37.0603 36.5685 13.8613
Liabilities 56.9923 51.8773 37.0603 36.5685 13.8613
Equity 10 10 10 10 3.249
Gross Profit 3.1328 4.2958 2.6089 2.4902 2.2754
Net Profit 2.1836 2.5658 1.897 1.7049 1.312
Cash From Operating Activities 15.4344 -6.7803 5.7311 -11.9487 1.0973
NPM(%) 4 3.82 4.3 3.48 3.34
Revenue 54.4608 67.1298 44.0368 48.8818 39.248
Expenses 51.328 62.834 41.4279 46.3916 36.9726
ROE(%) 4.73 5.56 4.11 3.7 2.84

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Medico Intercontinental Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sugal and Damani Share Brokers Ltd 65.00 -5.52 7.90 13.67 75.99 0.00
360 One Wam Ltd 1107.70 -0.37 36.92 860.10 2991.91 0.00
Arman Holdings Ltd 108.75 1.59 127.94 11.40 -0.29 0.00
Asia Capital Ltd 69.09 -2.00 160.67 6.77 4.39 0.00

Company Info

The Company's commitment to changing the course of human health through bold pursuits in science, life-enhancing therapies and a promise to always put patients first across the continents. We are providing a platform to all research based biopharmaceuticals companies reaching their Novel and innovative therapies to every part of the globe. From helping people obtain their medications to using cutting-edge scientific technology to discover new treatments, Medico's entrepreneurial spirit, teamwork-oriented culture and commitment to rare diseases create a unique platform for transforming patient outcomes. At every level, it is growing and evolving.1983-Incorporation of the Company1985-IPO of the Company1991-Change in registeed office ofl the comapny.2014-Preferential allotment of Shares of Shares2015 -Change in registered office of the Company from Delhi to Mumbai 2018- Company name has changed to Medico Intercontinental Ltd. from Intercontinental Leasing & Finance Company Ltd.

The Company's commitment to changing the course of human health through bold pursuits in science, life-enhancing therapies and a promise to always put patients first across the continents. We are providing a platform to all research based biopharmaceuticals companies reaching their Novel and innovative therapies to every part of the globe. From helping people obtain their medications to using cutting-edge scientific technology to discover new treatments, Medico's entrepreneurial spirit, teamwork-oriented culture and commitment to rare diseases create a unique platform for transforming patient outcomes. At every level, it is growing and evolving.1983-Incorporation of the Company1985-IPO of the Company1991-Change in registeed office ofl the comapny.2014-Preferential allotment of Shares of Shares2015 -Change in registered office of the Company from Delhi to Mumbai 2018- Company name has changed to Medico Intercontinental Ltd. from Intercontinental Leasing & Finance Company Ltd.

Read More

Parent Organisation

Medico Intercontinental Ltd.

Founded

14/08/1984

Managing Director

Mr.Samir Shah

NSE Symbol

FAQ

The current price of Medico Intercontinental Ltd is

The 52-week high for Medico Intercontinental Ltd is

The market capitalization of Medico Intercontinental Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Medico Intercontinental Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Medico Intercontinental Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Medico Intercontinental Ltd shares.

The CEO of Medico Intercontinental Ltd is Mr.Samir Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT